Haleon (HLN)

Sector:

Pharma and Biotech

Index:

FTSE 100

329.90p
   
  • Change Today:
      1.30p
  • 52 Week High: 346.55
  • 52 Week Low: 308.55
  • Currency: UK Pounds
  • Shares Issued: 9,132m
  • Volume: 31,717,296
  • Market Cap: £30,128m

Haleon Overview

Haleon plc is a consumer healthcare company. The Company’s product portfolio includes five categories, including oral health, vitamins, minerals, and supplements (VMS), pain relief, respiratory health, digestive health and others. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA and LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company's digestive health and other product offerings also include skin health and smoker’s health. Its oral health brands include Sensodyne, Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and Caltrate.

1 Day Chart (03-05-2024)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 1.8% 0.0%
Div Cover 2.9 n/a
Op Mrgn 17.7% n/a
ROCE 69.9%  
Latest F'cast
P/E 19.1 n/a
PEG n/a n/a
Pr/Revenue 2.7 n/a
Pr/Book 1.8  
Latest F'cast
Revenue 4.1% n/a
PBT 0.6% n/a
EPS -6.0% n/a
DPS 150.0% n/a

Haleon Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 9,545.00 1,636.00 17.90p n/a n/a n/a n/a 0.0%
31-Dec-22 10,858.00 1,618.00 18.40p 17.8 5.9 +3% 2.40p 0.7%
31-Dec-23 11,302.00 1,628.00 17.30p 18.6 n/a -6% 6.00p 1.9%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Haleon Company Announcements

Directorate Change 01-May-2024 11:10 RNS
Haleon 2024 Q1 Trading Statement 01-May-2024 07:00 RNS
Appointment of Dawn Allen as CFO 24-Apr-2024 07:00 RNS

Latest Haleon Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Haleon Market Data

Currency UK Pounds
Share Price 329.90p
Change Today 1.30p
% Change 0.40 %
52 Week High 346.55
52 Week Low 308.55
Volume 31,717,296
Shares Issued 9,132m
Market Cap £30,128m

Haleon Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
16.00% above the market average16.00% above the market average16.00% above the market average16.00% above the market average16.00% above the market average
84.31% above the sector average84.31% above the sector average84.31% above the sector average84.31% above the sector average84.31% above the sector average
Price Trend
11.41% above the market average11.41% above the market average11.41% above the market average11.41% above the market average11.41% above the market average
63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average
Income Not Available
Growth
38.45% below the market average38.45% below the market average38.45% below the market average38.45% below the market average38.45% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average

Haleon Dividends

  Latest Previous
  Final Interim
Ex-Div 14-Mar-24 24-Aug-23
Paid 16-May-24 05-Oct-23
Amount 4.20p 1.80p

Trades for 03-May-2024

Time Volume / Share Price
16:35 1,359,008 @ 329.46p
16:35 766,824 @ 329.46p
16:35 5,998,715 @ 329.90p
16:35 947 @ 329.90p
16:35 4,260 @ 329.90p

Haleon Key Personnel

CFO Tobias Hestler
CEO Brian McNamara
CEO Deirdre Mahlan

Top of Page